Iqvia Holdings Inc Stock Nyse
Equities
US74876Y1010
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | 15.49B | Sales 2025 * | 16.58B | Capitalization | 42.11B |
---|---|---|---|---|---|
Net income 2024 * | 1.34B | Net income 2025 * | 1.58B | EV / Sales 2024 * | 3.48 x |
Net Debt 2024 * | 11.83B | Net Debt 2025 * | 11.7B | EV / Sales 2025 * | 3.25 x |
P/E ratio 2024 * |
31.5
x | P/E ratio 2025 * |
26.4
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 69.84% |
Latest transcript on Iqvia Holdings Inc
Managers | Title | Age | Since |
---|---|---|---|
Ari Bousbib
CEO | Chief Executive Officer | 63 | 16-10-02 |
Ronald Bruehlman
DFI | Director of Finance/CFO | 63 | 20-07-31 |
James Berkshire
COO | Chief Operating Officer | 51 | 17-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Danhakl
BRD | Director/Board Member | 67 | 16-10-02 |
Colleen Goggins
BRD | Director/Board Member | 68 | 17-07-26 |
Ari Bousbib
CEO | Chief Executive Officer | 63 | 16-10-02 |
1st Jan change | Capi. | |
---|---|---|
+29.77% | 49.18B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.68% | 26.09B | |
-22.99% | 18.71B | |
+8.22% | 13.26B | |
+32.41% | 12.32B | |
-1.62% | 11.99B | |
+24.01% | 11.97B |